Dr. Murakami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana-Farber Cancer Institute, Smith Building, Room 357
Boston, MA 02215Phone+1 617-632-3779Fax+1 617-632-5822
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
Washington University in St. Louis School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2011 - 2026
Publications & Presentations
PubMed
- 94 citationsTargeting minimal residual disease: a path to cure?Marlise R. Luskin, Mark A. Murakami, Scott R. Manalis, David M. Weinstock
Nature Reviews. Cancer. 2018-01-29 - 128 citationsDistinction of lymphoid and myeloid clonal hematopoiesisAbhishek Niroula, Aswin Sekar, Mark A. Murakami, Mark Trinder, Mridul Agrawal
Nature Medicine. 2021-10-18 - 416 citationsIntegration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prosp...Alessandro Pastore, Vindi Jurinovic, Robert Kridel, Eva Hoster, Annette M. Staiger
The Lancet. Oncology. 2015-09-01
Abstracts/Posters
- A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older AdultsMark A. Murakami, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Signaling Input from Divergent Pathways Subverts Malignant B-Cell TransformationMark A. Murakami, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
South Africa: Two International Awards for UCT's Katherine AntelAugust 2nd, 2022
New Public Repository of Patient-Derived Cancer Models Aims to Improve Drug TestingApril 11th, 2016
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
